Hide Ya Wives, Hide Ya Kids: Worldwide Coronavirus Pandemic!

Are You Getting The Covid Vaccine?

  • Yes

  • No

  • Only if mandatory

  • Not if mandatory

  • Undecided


Results are only viewable after voting.
Anyone has the video footage of the idiot suggesting that people ingest Clorox to cure Covid...?

lmao
 
Nah man, this CAnt be life, this dude is the biggest MORON on the planet :rofl:

son really thinks Clorox Can clean the insides of the lungs the same way we use it to wipe a toilet bowl :lol:

It really is no surprise his base are all idiots, he really is one of them....my lord..
 
pmetqgn2aqu41.jpg

 
83% SURVIVAL IN COVID-19 PATIENTS WITH MODERATE/SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME TREATED IN NEW YORK WITH MESOBLAST’S CELL THERAPY REMESTEMCEL-L

Key points:
• 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated with two infusions of Mesoblast’s allogeneic cell therapy remestemcel-L within the first five days under emergency compassionate use at New York City’s Mt Sinai hospital during the period March-April 2020
• 75% (9/12) have successfully come off ventilator support within a median of 10 days
• These results contrast with only 9% of ventilator-dependent COVID-19 patients being able to come off ventilators with standard of care treatment and only 12% survival in ventilator-dependent COVID-19 patients at two major referral hospital networks in New York during the same time period1,2
• This compassionate use treatment experience has informed the design of the clinical protocol for the randomized, placebo-controlled Phase 2/3 trial of remestemcel-L in ventilator-dependent COVID-19 moderate/severe ARDS patients across North America Melbourne, Australia; April 24, 2020; and New York, USA; April 23, 2020: Mesoblast Limited (ASX:MS
 
Back
Top Bottom